GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Senzime AB (OSTO:SEZI) » Definitions » Selling and Marketing Expense

Senzime AB (OSTO:SEZI) Selling and Marketing Expense : kr84.28 Mil (TTM As of Mar. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Senzime AB Selling and Marketing Expense?

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services. Senzime AB's Selling and Marketing Expense for the three months ended in Mar. 2024 was kr22.19 Mil. Its Selling and Marketing Expense for the trailing twelve months (TTM) ended in Mar. 2024 was kr84.28 Mil.

Senzime AB Selling and Marketing Expense Historical Data

The historical data trend for Senzime AB's Selling and Marketing Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Senzime AB Selling and Marketing Expense Chart

Senzime AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Selling and Marketing Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.88 16.05 39.53 70.05 77.68

Senzime AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Selling and Marketing Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.60 21.40 18.36 22.33 22.19

Senzime AB Selling and Marketing Expense Calculation

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services.

Selling and Marketing Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr84.28 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Senzime AB Selling and Marketing Expense Related Terms

Thank you for viewing the detailed overview of Senzime AB's Selling and Marketing Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Senzime AB (OSTO:SEZI) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Senzime AB (OSTO:SEZI) » Definitions » Selling and Marketing Expense
Comparable Companies
OSTO:BRAIN OSTO:MNTC OSTO:PRO OSTO:INTEG B OSTO:STIL OSTO:PAX OSTO:CRAD B OSTO:SPEC OSTO:OSSD OSTO:BOUL ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA
Traded in Other Exchanges
SNZZF:USA 6YC:Germany
Address
Ulls vag 41, Uppsala, SWE, 756 51
Website
https://www.senzime.com
Senzime AB, a medical technology company, develops, manufactures, and markets patient monitoring systems for monitoring patients. Its solutions are designed to ensure maximum patient benefit, reduce complications associated with surgery and anesthesia, and decrease healthcare costs. Its product includes TetraGraph and TetraSens, ExSpiron, TetraSens Pediatric, and TetraConnect. Its geographical segments include Sweden, the United States, Europe/Oceania, and Asia.

Senzime AB (OSTO:SEZI) Headlines

No Headlines